Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa

Pharmazie

Volumn 65, Issue 3, 2010, Pages 194-198

  Choudhary, H ^a   Agrawal, A K ^a   Malviya, R ^a   Yadav, S K ^a   Jaliwala, Y A ^a   Patil, U K ^a  

^a VNS Institute of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE; POLYMER;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DIFFUSION; DRUG ABSORPTION; DRUG EFFICACY; DRUG RELEASE; EMULSION; ENCAPSULATION; LINEAR REGRESSION ANALYSIS; PARTICLE SIZE; SURFACE PROPERTY;

ANTIPARKINSON AGENTS; CARBIDOPA; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; DRUG COMPOUNDING; KINETICS; LEVODOPA; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; SOLUBILITY;

EID: 77949357351     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9288     Document Type: Article

References (17)

1. Arica B, Sqheyla KaYH, Amir M, Akalan N (2005) Carbidopa/levodopa-loaded biodegradable microspheres: in vivo evaluation on experimental parkinsonism in rats. J Control Release 102: 689-697.
2. Fell JT and Collet JH (2000) Prolonged gastric retention using floating dosage forms. Pharm Technol 3: 82-90.
3. Goole J, Deleuze P, Vanderbist F, Amighi K (2008) Newlevodopa sustained-release floating minitablets coated with insoluble acrylic polymer. Eur J Pharm Biopharm 68: 310-318.
4. Goole J, Vanderbist F, Amighi K (2007) Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm 334: 35-41.
5. Ianuccelli V, Coppi G, Bernabei MT, Cameroni R (1998) Air compartment multiple-unit system for prolonged gastric residence Part I. Formulation study. Int J Pharm 174: 47-54.
6. Kao HD, Traboulsi A, Itoh S, Hussain A (2000) Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs. Pharm Res 17: 978-984.
7. Kawashima Y, Niwa T, Takechi H, Hino T, Itoh Y (1992) Hollow microspheres for use as floating controlled drug delivery systems in the stomach. J Pharm Sci 81: 135-140.
8. Klausner EA, Lavy E, Friedman M, Hoffman A (2003) Expandable gastroretentive dosage forms. J Control Release 90: 143-162.
9. Safavi A, Tohidi M (2007) Simultaneous kinetic determination of levodopa and carbidopa by H-point standard addition method. J Pharm Biomed Anal 44: 313-318.
10. Sahoo SK, Mallick AA, Barik BB, Senapati PC (2007) Preparation and in vitro evaluation of ethyl cellulose microspheres containing stavudine by the double emulsion method. Pharmazie 62: 117-121.
11. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H (2003a) In vivo evaluation of riboflavin containing microballons for floating controlled drug delivery system in healthy human volunteers. J Control Release 93: 39-47.
12. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H (2003b) Physicochemical properties to determine the buoyancy of hollow microspheres (microballons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 55: 297-304.
13. Sato Y, Kawashima Y, Takeuchi H, Yamaoto H (2004) In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int J Pharm 275: 97-107.
14. Srivastava AK, Ridhurkar DN, Wadhwa S (2005) Floating microspheres of cimetidine formulation, characterization and in vitro evaluation. Acta Pharm 55: 277-285.
15. Talukder R, Fassihi R (2004) Gastroretentive delivery systems a mini review. Drug Dev Ind Phar 30: 1019-1028.
16. Talwar N, Sen H, Staniforth JN (2001) Orally administered controlled drug delivery system providing temporal and spacial control. US Patent 6261601.
17. Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM (1998) Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Release 55: 3-12.